With two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the memory-robbing condition. But tests to detect the condition still lag behind.

"It is still possible to detect AD pathology, but not as precisely as one would like or in the way that is often suggested. A positive p-tau test could, for example, prompt physicians to perform other ...

Testing a person’s blood for a type of protein called phosphorylated tau, or p-tau, could be used to screen for Alzheimer’s disease with “high accuracy,” even before symptoms begin to show, a new ...

An estimated 55 million people around the world are living with Alzheimer’s Disease or another form of dementia. A newly published study from Sweden unveiled a blood test capable of detecting ...

A biomarker test identified tau pathology in Alzheimer's disease before fibrillary tangles developed. Neurofibrillary tangle formation can be prevented by targeting intermediate soluble tau assemblies ...

New test elevates the performance standard for blood biomarker tests intended for detecting amyloid pathology in individuals with cognitive impairment BILLERICA, Mass.--(BUSINESS WIRE)--Lucent ...

Please provide your email address to receive an email when new articles are posted on . A clinical diagnostics company and biotech firm have announced a partnership to develop a blood-based tau ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

A few weeks ago, I had a blood test that might revolutionise diagnosis and treatment for Alzheimer’s disease, a terrible condition affecting millions worldwide for which there is currently no cure.

Testing a person's blood for a type of protein called phosphorylated tau, or p-tau, could be used to screen for Alzheimer's disease with "high accuracy," even before symptoms begin to show, a new ...